Exploring the clinical effect of group psychotherapy of traditional Chinese medicine on generalized anxiety disorder and the influence of prefrontal function based on fNIRS

注册号:

Registration number:

ITMCTR2022000086

最近更新日期:

Date of Last Refreshed on:

2022-08-26

注册时间:

Date of Registration:

2022-06-27

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

基于fNIRS探索中医团体心理疗法对广泛性焦虑障碍的临床疗效及前额叶功能的影响

Public title:

Exploring the clinical effect of group psychotherapy of traditional Chinese medicine on generalized anxiety disorder and the influence of prefrontal function based on fNIRS

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于fNIRS探索中医团体心理疗法对广泛性焦虑障碍的临床疗效及前额叶功能的影响

Scientific title:

Exploring the clinical effect of group psychotherapy of traditional Chinese medicine on generalized anxiety disorder and the influence of prefrontal function based on fNIRS

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2200062963 ; ChiMCTR2200006541

申请注册联系人:

林颖娜

研究负责人:

林颖娜

Applicant:

LIN Yingna

Study leader:

LIN Yingna

申请注册联系人电话:

Applicant telephone:

13810123859

研究负责人电话:

Study leader's telephone:

13810123859

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

lin80327@126.com

研究负责人电子邮件:

Study leader's E-mail:

lin80327@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

北京西城北线阁5号

研究负责人通讯地址:

北京西城北线阁5号

Applicant address:

No. 5, Bei Xicheng, Beijing

Study leader's address:

No. 5, Bei Xicheng, Beijing

申请注册联系人邮政编码:

Applicant postcode:

100053

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国中医科学院广安门医院

Applicant's institution:

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2022-153-KY

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

中国中医科学院广安门医院伦理委员会

Name of the ethic committee:

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2022/7/12 0:00:00

伦理委员会联系人:

乔洁

Contact Name of the ethic committee:

QIAO JIE

伦理委员会联系地址:

北京西城区北线阁5号

Contact Address of the ethic committee:

5 Bei Xicheng, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国中医科学院广安门医院

Primary sponsor:

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine

研究实施负责(组长)单位地址:

北京西城北线阁5号

Primary sponsor's address:

No. 5, Bei Xicheng, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

中国中医科学院广安门医院

具体地址:

北京西城北线阁5号

Institution
hospital:

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine

Address:

No. 5, Bei Xicheng, Beijing

经费或物资来源:

中国中医科学院

Source(s) of funding:

Chinese Academy of traditional Chinese Medicine

研究疾病:

焦虑障碍

研究疾病代码:

Target disease:

Anxiety disorder

Target disease code:

研究类型:

Study type:

预防性研究

Prevention

研究设计:

Study design:

病例对照研究

Case-Control study

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

1. 探索一种适用于广泛性焦虑障碍的中医团体心理方案,并对其安全性、有效性进行验证; 2.制定中医团体心理疗法治疗广泛性焦虑障碍的技术规范,编制临床实践指南,在全国推广应用; 3. 通过与团体认知行为治疗组的近红外光谱成像测试结果比较,从前额叶脑血氧水平信号变化寻找中医团体心理疗法对大脑的特异性作用; 4.通过分析近红外光谱成像数据变化与心理量表的改变量的相关关系,寻找中医团体心理疗法治疗广泛性焦虑障碍的前额叶皮层的作用靶点。

Objectives of Study:

1. Exploring a TCM group psychological program suitable for generalized anxiety disorder, and verify its safety and effectiveness; 2. Develop technical specifications for the treatment of generalized anxiety disorder by TCM group psychotherapy, and compile clinical practice guidelines. National promotion and application; 3. By comparing the results of the near-infrared spectral imaging test with the group cognitive behavioral therapy group, the specific effect of traditional Chinese medicine group psychotherapy on the brain was found from the signal changes of the prefrontal cerebral blood oxygen level; 4. By analyzing the near-infrared The correlation between the changes of spectral imaging data and the changes of psychological scales, and the target of the prefrontal cortex of TCM group psychotherapy in the treatment of generalized anxiety disorder.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)年龄:18~60周岁,男女均可; (2)符合西医广泛性焦虑障碍诊断标准; (3)入组时HAMA焦虑量表(17项)总分≥14分,且≤29分; (4)入组时HAMD抑郁量表总分≤7分; (5)知情同意并签署知情同意书。

Inclusion criteria

(1) Age: 18-60 years old, both male and female; (2) Meet the diagnostic criteria for generalized anxiety disorder in Western medicine; (3) HAMA anxiety scale (17 items) total score ≥ 14 points and ≤ 29 points at the time of enrollment ; (4) The total score of HAMD depression scale at the time of enrollment is ≤ 7 points; (5) Informed consent and signed informed consent.

排除标准:

排除标准:1)有脑器质性疾病史; 2)妊娠及哺乳期妇女;3)患有严重躯体疾病者。

Exclusion criteria:

Exclusion criteria: 1) History of organic brain disease; 2) Pregnant and lactating women; 3) Those with severe physical disease.

研究实施时间:

Study execute time:

From 2021-10-01

To      2024-10-01

征募观察对象时间:

Recruiting time:

From 2022-08-21

To      2022-12-01

干预措施:

Interventions:

组别:

中医团体心理治疗组

样本量:

30

Group:

TCM group psychotherapy group

Sample size:

干预措施:

中医心理干预

干预措施代码:

Intervention:

TCM group psychotherapy

Intervention code:

组别:

团体认知行为治疗组

样本量:

30

Group:

CBT group psychotherapy

Sample size:

干预措施:

认知行为团体治疗

干预措施代码:

Intervention:

CBT psychotherapy

Intervention code:

样本总量 Total sample size : 60

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

北京

City:

单位(医院):

中国中医科学院广安门医院

单位级别:

三级甲等

Institution/hospital:

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine

Level of the institution:

Class III class A

测量指标:

Outcomes:

指标中文名:

脱氧血红蛋白

指标类型:

主要指标

Outcome:

Deoxy-Hb

Type:

Primary indicator

测量时间点:

0、6周

测量方法:

红外热成像技术

Measure time point of outcome:

Measure method:

指标中文名:

明尼苏达多项人格测试

指标类型:

主要指标

Outcome:

MMPI

Type:

Primary indicator

测量时间点:

0、6周

测量方法:

计算机量表

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿抑郁量表

指标类型:

主要指标

Outcome:

HAMD

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿焦虑量表

指标类型:

主要指标

Outcome:

HAMA

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血红蛋白

指标类型:

主要指标

Outcome:

Hb

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 18
Min age years
最大 60
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

运用EXCEL中的Rand函数

Randomization Procedure (please state who generates the random number sequence and by what method):

Using Rand function in Excel

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2050

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

2050

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above